Special clinical interests in triple-negative breast cancers, HER2 positive disease, BRCA mutation carriers, lifestyle strategies in reducing breast cancer recurrence and male breast cancers
Dr Shiroma De Silva-Minor is a Consultant Oncologist specialising in the oncological management of breast cancers.
Dr De Silva-Minor graduated from University of Wales College of Medicine, Cardiff in 1995 and became a Member of the Royal College of Physicians (UK) in 1999. Having chosen to specialise in Clinical Oncology, Dr De Silva-Minor trained as a specialist registrar in London, working at nationally renowned cancer centres at UCL The Middlesex Hospital, The Royal Free and The Royal Marsden Hospital among others. She became a Fellow of the Royal College of Radiologists (UK) in 2003.
Dr De Silva-Minor undertook a Fellowship in Head and Neck Radiation Oncology at The Princess Margaret Hospital, Toronto, Canada where she was awarded the Prize for Academic Excellence.
Dr De Silva-Minor has presented her research at international conferences including: the annual meeting of the Canadian Association of Radiation Oncologists (CARO) in British Columbia; the American Society for Therapeutic Radiology and Oncology (ASTRO) in Colorado in 2005 and in Philadelphia in November 2006; and at the European Society of Therapeutic Radiation and Oncology (ESTRO) in September 2007.
Dr De Silva-Minor was appointed Consultant Clinical Oncologist at The Oxford University Hospitals NHS Trust in 2008. Based at the Churchill Hospital in Oxford, she also practises at: The Great Western Hospital, Swindon; BMI The Ridgeway in Wroughton; and at the GenesisCare Centre, Oxford.
- Hormone therapy
NHS Hospital / current post(s)
- Consultant Clinical Oncologist, Oxford Cancer Centre and Oxford University Hospitals NHS Foundation Trust
- Fellow of the Royal College of Radiologists (FRCR)
- Fellow of the Royal College of Physicians (FRCP)
- Member of the European Society for Therapeutic Radiology and Oncology (ESTRO)
Awarded the Prize for Academic Excellence by the University of Toronto for research into the use of PET CT for identifying head & neck tumours for radiotherapy treatment.